Literature DB >> 30982966

PGC-1α deficiency causes spontaneous kidney inflammation and increases the severity of nephrotoxic AKI.

Miguel Fontecha-Barriuso1,2, Diego Martín-Sánchez1,2, Julio M Martinez-Moreno1, Susana Carrasco1,2, Olga Ruiz-Andrés1,2, Maria Monsalve3, Cristina Sanchez-Ramos3, Manuel J Gómez4, Marta Ruiz-Ortega1,2,5, Maria D Sánchez-Niño1,2, Pablo Cannata-Ortiz6, Ramiro Cabello1, Carmen Gonzalez-Enguita1, Alberto Ortiz1,2,5,7, Ana B Sanz1,2.   

Abstract

PGC-1α (peroxisome proliferator-activated receptor gamma coactivator-1α, PPARGC1A) regulates the expression of genes involved in energy homeostasis and mitochondrial biogenesis. Here we identify inactivation of the transcriptional regulator PGC-1α as a landmark for experimental nephrotoxic acute kidney injury (AKI) and describe the in vivo consequences of PGC-1α deficiency over inflammation and cell death in kidney injury. Kidney transcriptomic analyses of WT mice with folic acid-induced AKI revealed 1398 up- and 1627 downregulated genes. Upstream transcriptional regulator analyses pointed to PGC-1α as the transcription factor potentially driving the observed expression changes with the highest reduction in activity. Reduced PGC-1α expression was shared by human kidney injury. Ppargc1a-/- mice had spontaneous subclinical kidney injury characterized by tubulointerstitial inflammation and increased Ngal expression. Upon AKI, Ppargc1a-/- mice had lower survival and more severe loss of renal function, tubular injury, and reduction in expression of mitochondrial PGC-1α-dependent genes in the kidney, and an earlier decrease in mitochondrial mass than WT mice. Additionally, surviving Ppargc1a-/- mice showed higher rates of tubular cell death, compensatory proliferation, expression of proinflammatory cytokines, NF-κB activation, and interstitial inflammatory cell infiltration. Specifically, Ppargc1a-/- mice displayed increased M1 and decreased M2 responses and expression of the anti-inflammatory cytokine IL-10. In cultured renal tubular cells, PGC-1α targeting promoted spontaneous cell death and proinflammatory responses. In conclusion, PGC-1α inactivation is a key driver of the gene expression response in nephrotoxic AKI and PGC-1α deficiency promotes a spontaneous inflammatory kidney response that is magnified during AKI.
© 2019 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. © 2019 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  PGC-1α; acute kidney injury; cell death; inflammation; mitochondria; proximal tubule

Mesh:

Substances:

Year:  2019        PMID: 30982966     DOI: 10.1002/path.5282

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  21 in total

1.  Erythropoietin promotes energy metabolism to improve LPS-induced injury in HK-2 cells via SIRT1/PGC1-α pathway.

Authors:  Kan Li; Li Gao; Sen Zhou; Yan-Rong Ma; Xiao Xiao; Qian Jiang; Zhi-Hong Kang; Ming-Long Liu; Tian-Xi Liu
Journal:  Mol Cell Biochem       Date:  2022-08-24       Impact factor: 3.842

Review 2.  Targeting energy pathways in kidney disease: the roles of sirtuins, AMPK, and PGC1α.

Authors:  Amanda J Clark; Samir M Parikh
Journal:  Kidney Int       Date:  2020-12-08       Impact factor: 10.612

Review 3.  Epigenetic Modifiers as Potential Therapeutic Targets in Diabetic Kidney Disease.

Authors:  Julio M Martinez-Moreno; Miguel Fontecha-Barriuso; Diego Martin-Sanchez; Juan Guerrero-Mauvecin; Elena Goma-Garces; Beatriz Fernandez-Fernandez; Sol Carriazo; Maria D Sanchez-Niño; Adrian M Ramos; Marta Ruiz-Ortega; Alberto Ortiz; Ana B Sanz
Journal:  Int J Mol Sci       Date:  2020-06-09       Impact factor: 5.923

4.  PGC-1α Suppresses the Activation of TGF-β/Smad Signaling via Targeting TGFβRI Downregulation by let-7b/c Upregulation.

Authors:  Hoon-In Choi; Jung Sun Park; Dong-Hyun Kim; Chang Seong Kim; Eun Hui Bae; Seong Kwon Ma; Soo Wan Kim
Journal:  Int J Mol Sci       Date:  2019-10-14       Impact factor: 5.923

Review 5.  Exploring Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors for Organ Protection in COVID-19.

Authors:  Beatriz Fernandez-Fernandez; Luis D'Marco; Jose Luis Górriz; Conxita Jacobs-Cachá; Mehmet Kanbay; Sergio Luis-Lima; Esteban Porrini; Pantelis Sarafidis; María José Soler; Alberto Ortiz
Journal:  J Clin Med       Date:  2020-06-28       Impact factor: 4.241

6.  Activator-Mediated Pyruvate Kinase M2 Activation Contributes to Endotoxin Tolerance by Promoting Mitochondrial Biogenesis.

Authors:  Zhujun Yi; Yilin Wu; Wenfeng Zhang; Tao Wang; Jianping Gong; Yao Cheng; Chunmu Miao
Journal:  Front Immunol       Date:  2021-01-19       Impact factor: 7.561

Review 7.  Renal Reabsorption of Folates: Pharmacological and Toxicological Snapshots.

Authors:  Sophia L Samodelov; Zhibo Gai; Gerd A Kullak-Ublick; Michele Visentin
Journal:  Nutrients       Date:  2019-10-02       Impact factor: 5.717

8.  Molecular pathways driving omeprazole nephrotoxicity.

Authors:  Miguel Fontecha-Barriuso; Diego Martín-Sanchez; Julio M Martinez-Moreno; Daniela Cardenas-Villacres; Susana Carrasco; Maria D Sanchez-Niño; Marta Ruiz-Ortega; Alberto Ortiz; Ana B Sanz
Journal:  Redox Biol       Date:  2020-02-12       Impact factor: 11.799

Review 9.  PGC-1α in Disease: Recent Renal Insights into a Versatile Metabolic Regulator.

Authors:  Joseph M Chambers; Rebecca A Wingert
Journal:  Cells       Date:  2020-10-03       Impact factor: 6.600

10.  Stat2-Drp1 mediated mitochondrial mass increase is necessary for pro-inflammatory differentiation of macrophages.

Authors:  Weihua Yu; Xin Wang; Jiuzhou Zhao; Rui Liu; Jiangzheng Liu; Zhao Wang; Jie Peng; Hao Wu; Xiaodi Zhang; Zi Long; Deqin Kong; Wenli Li; Chunxu Hai
Journal:  Redox Biol       Date:  2020-10-14       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.